Innoviva (INVA) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 707.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 707.85% |
| Dec 31, 2025 | -31.16% |
| Sep 30, 2025 | 1,328.19% |
| Jun 30, 2025 | 284.83% |
| Mar 31, 2025 | -185.52% |
| Dec 31, 2024 | -60.22% |
| Sep 30, 2024 | -92.03% |
| Jun 30, 2024 | -776.64% |
| Mar 31, 2024 | 9.68% |
| Dec 31, 2023 | 36.31% |
| Sep 30, 2023 | -69.99% |
| Jun 30, 2023 | -71.68% |
| Mar 31, 2023 | -8.00% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | 132.53% |
| Jun 30, 2022 | -84.95% |
| Mar 31, 2022 | -65.45% |
| Dec 31, 2021 | -106.66% |
| Sep 30, 2021 | 143.98% |
| Jun 30, 2021 | 15.29% |
| Mar 31, 2021 | 36.41% |
| Dec 31, 2020 | 29.17% |
| Sep 30, 2020 | -12.36% |
| Jun 30, 2020 | 109.08% |
| Mar 31, 2020 | 95.53% |
| Dec 31, 2019 | -3.93% |
| Sep 30, 2019 | 14.83% |
| Jun 30, 2019 | -0.22% |
| Mar 31, 2019 | 60.00% |
| Dec 31, 2018 | 141.32% |
| Sep 30, 2018 | 47.42% |
| Jun 30, 2018 | 57.56% |
| Mar 31, 2018 | 80.56% |
| Dec 31, 2017 | 22.06% |
| Sep 30, 2017 | 127.21% |
| Jun 30, 2017 | 179.02% |
| Mar 31, 2017 | 276.05% |
| Dec 31, 2016 | 477.35% |
| Sep 30, 2016 | 426.72% |
| Jun 30, 2016 | 264.89% |
| Mar 31, 2016 | 141.88% |
| Dec 31, 2015 | 127.01% |
| Sep 30, 2015 | 78.73% |
| Jun 30, 2015 | 60.70% |
| Mar 31, 2015 | 34.08% |
| Dec 31, 2014 | -79.06% |
| Sep 30, 2014 | -127.94% |
| Jun 30, 2014 | -1,189.62% |
| Mar 31, 2014 | 54.97% |
| Dec 31, 2013 | 79.54% |
| Sep 30, 2013 | 72.75% |
| Jun 30, 2013 | 95.85% |
| Mar 31, 2013 | -142.48% |
| Dec 31, 2012 | -17.47% |
| Sep 30, 2012 | -13.28% |
| Jun 30, 2012 | -48.21% |
| Mar 31, 2012 | 470.83% |
| Dec 31, 2011 | -90.37% |
| Sep 30, 2011 | -44.31% |
| Jun 30, 2011 | -20.37% |